Dr. Cynthia Calkin, a pioneering researcher in the field of bipolar disorder, reveals groundbreaking insights into using Metformin for treatment-resistant cases. Her work shows that improving insulin resistance can dramatically enhance depression outcomes. Calkin emphasizes the importance of recognizing metabolic dysfunction as a significant factor in mental health. This innovative approach challenges traditional psychiatric methods, advocating for metabolic strategies to transform patient care. It's a call to integrate physical health into mental health treatments!

Dr. Shebani Sethi, a psychiatrist at Stanford specializing in metabolic mental health, and Dr. Cynthia Calkin from Dalhousie, an expert in psychiatric therapies, dive into the fascinating link between metabolic health and mental illness. They discuss how therapies like nutritional ketosis and metformin might alleviate severe psychiatric symptoms. The conversation highlights the significance of robust clinical trials and shares insights on how these findings can impact real-world patient care, especially for those seeking alternative treatment options.